{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:13:50Z","timestamp":1779196430907,"version":"3.51.4"},"reference-count":5,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Febrile episodes in oncology is common are mostly of infectious etiology requiring repeated investigations and escalation of antibiotics. But, drug induced fever occur more often than we think in oncological set-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Report<\/jats:title>\n                    <jats:p>A 5 year old male child with rhabdomyosarcoma, developed high grade fever spikes following Vincristine monotherapy. Infective etiology work up was negative and the fever responded to corticosteroids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Management and Outcome<\/jats:title>\n                    <jats:p>He was treated with corticosteroids as premedication considering vincristine induced fever. The further courses of VCR- monotherapy were uneventful with steroids as premedication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We present the case of vincristine induced fever in a child with embryonal rhabdomyosarcoma. Clinician\u2019s should consider drug induced fever at appropriate conditions, to avoid leading to antibiotic resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552221074015","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T07:10:33Z","timestamp":1641971433000},"page":"1209-1210","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Vincristine induced fever in a child with embryonal rhadbomyosarcoma"],"prefix":"10.1177","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-9378","authenticated-orcid":false,"given":"Dr. Arul","family":"Janani","sequence":"first","affiliation":[{"name":"Sri Ramachandra Institute of Higher education and Research (SRI HER)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr. Anandkumar","family":"Shruthilaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr. Jayaraman","family":"Dhaarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr. Scott X","family":"Julius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.4.552"},{"key":"e_1_3_2_3_2","first-page":"529","article-title":"A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review","volume":"55","author":"Rosenfelt F","unstructured":"Rosenfelt F, Palmer J, Weinstein I, et al. A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review. Yale J Biol Med 1982 Sep-Dec; 55: 529\u2013531.","journal-title":"Yale J Biol Med"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880215)61:4<660::AID-CNCR2820610407>3.0.CO;2-2"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/107327481702400212"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200101000-00020"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552221074015","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552221074015","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552221074015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:37:46Z","timestamp":1779194266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552221074015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1177\/10781552221074015"],"URL":"https:\/\/doi.org\/10.1177\/10781552221074015","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}